Richard Delorme is head of the Center of Excellence for Autism Spectrum Disorders and Neurodevelopmental Disorders (InovAND) and head of the Department of Child and Adolescent Psychiatry at the Robert Debré Hospital, both in Paris, France. He has a broad background in child psychiatry and genetics, with expertise in the identification of biomarkers in rare diseases associated with autism. He is also a researcher at the Human Genetics and Cognitive Functions Laboratory at the Institut Pasteur, in Paris. In recent years, he has been involved in several research programs, brain imaging studies and IPSC-based drug screening technology. He is an author on more than 100 publications.
Richard Delorme
Head
Center of Excellence for Autism Spectrum Disorders and Neurodevelopmental Disorders
From this contributor
Coronavirus tool kit may aid families with autistic children during lockdown
To help families cope with the sudden loss of professional support during the pandemic, one team in France has created a set of resources and information.
Coronavirus tool kit may aid families with autistic children during lockdown
By
Richard Delorme, Benjamin Landman
21 April 2020 | 4 min read
Explore more from The Transmitter
SHANK3 deficiency and behavior in mice; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 November.
SHANK3 deficiency and behavior in mice; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 24 November.
By
Jill Adams
25 November 2025 | 2 min read
Remembering Mark Hallett, leader in transcranial magnetic stimulation
The long-time NINDS researcher, best known for studying movement disorders, has died at age 82.
Remembering Mark Hallett, leader in transcranial magnetic stimulation
The long-time NINDS researcher, best known for studying movement disorders, has died at age 82.
By
David Dobbs
25 November 2025 | 7 min read
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
By
The Transmitter
21 November 2025 | 6 min read